Creso Pharma Share Price and Company Fundamentals



Price
$0.039
Change
0.001 (2.632%)
52 week
0.035 - 0.16

Last traded: Today at 12:29 AM

Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific. The company develops and commercializes therapeutic products; and cultivates, processes, and sells cannabis products, as well as supplies cannabis retail products. Its products include anibidiol, a complementary feed product for companion animals; cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and zinc that reduces stress and supports psychological and nervous functions; and topical and skin care products, which include cannaDOL, a CBD-based topical gel associated with a mixture of cooling and warming essential oils. Creso Pharma Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.

Key Metrics

PE ratio

-

PB ratio

2.29

Dividend yield

0.00%

Beta

3.38

Market cap

-

Enterprise value

-

Company profile

Primary activitiesDeveloping, registering and commercialising pharmaceutical-grade cannabis and hemp-based products for use across a broad spectrum of consumer,. Industry and research applications.
Industry / SectorDrug Manufacturers—Specialty & Generic / Healthcare
Websitehttps://www.cresopharma.com
Mailing address145 Stirling Highway Suite 5 CPC Nedlands WA 6009 Australia
Phone / Fax61 8 9389 3180 / 61 8 9389 3199
Share registryAUTOMIC REGISTRY SERVICES

Dividends

More: Creso Pharma Dividend history, yield and payout ratio

Dividend yield

0.00%

Dividend amount

$0.00

Payout ratio

0.00%

Creso Pharma paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.CPH dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

CPH's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Aug 2022, following are the company executives and directors listed on Creso Pharma.

NameTitleAgeTotal Pay
Dr. James Anthony Ellingford AICD, D.Mgt, M.B.A., MBA, PG(Corp Mgmt), Ph.D.Exec. Chairman510.24k
Mr. Boaz Wachtel M.A., M.D., MBACo-Founder & Non-Exec. Director6097.14k
Mr. Adam Blumenthal B.Com., M.B.A.Co-Founder & Non-Exec. Director314.5k
Mr. Christopher GrundyChief Financial Officer501.65k
Mr. William Lay B.Com.Group CEO, MD & Director
Dr. Gian TreppCommercial & Marketing Director
Ms. Micheline MacKay B.Sc., M.Sc., P.M.P.MD & Exec. Director
Ms. Erlyn Saromines Dawson A.C.I.S., ACIS, AGIA, B.Com., BCom., GradDipACGJoint Company Sec.
Mr. Winton William Willesee C.P.A., GAICD, MAICD, MComJoint Company Sec.51
Dr. Simon H. W. BuckinghamConsultant59

Profitability and management effectiveness

Profit margin

0.00%

Operating margin

-455.94%

Return on assets

-73.17%

Return on equity

-145.04%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Creso Pharma is and its enterprise value is .

The CPH's stocks Beta value is 3.38 making it 238% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Creso Pharma (CPH)

Creso Pharma (ASX:CPH) Frequently Asked Questions

1. What is Creso Pharma's Stock Symbol?

Creso Pharma trades on ASX under the ticker symbol "CPH".

2. What is Creso Pharma's stock price today?

One share of CPH stock can currently be purchased for approximately $0.039.

3. How can I contact Creso Pharma?

Creso Pharma's mailing address is 145 Stirling Highway Suite 5 CPC Nedlands WA 6009 Australia. The company can be reached via phone at 61 8 9389 3180.

4. What is Creso Pharma's official website?

The official website of Creso Pharma is https://www.cresopharma.com.

5. Which share registry manages Creso Pharma's stock?

Creso Pharma's stock is managed by AUTOMIC REGISTRY SERVICES.